Skip to main content

Table 2 Surgical outcomes of cytoreductive surgery

From: A novel algorithm for the treatment strategy for advanced epithelial ovarian cancer: consecutive imaging, frailty assessment, and diagnostic laparoscopy

 

PDS

DLS

NACT

P

n = 85

n = 38

n = 58

OP time, min [IQR]

365.0 [216.5; 476.5]

266.2 [160.3; 193.5]

339.0 [205; 425]

0.042

Blood loss, mL [IQR]

962.2 [300; 1037.5]

267.1 [150; 450]

861.7 [150; 1200]

0.023

Transfusion

38 (44.7%)

9 (23.7%)

28(48.3%)

0.016

ΔHb [IQR]

1.0 [0; 1.98]

1.0 [0; 1.8]

0.1 [−0.5; 1.8]

<0.001

ICU admission

32 (37.6%)

4 (10.5%)

22 (37.9%)

0.006

Optimum

80 (94.1%)

37 (97.4%)

53 (91.4%)

0.484

Residual disease

 < 0.5 cm

70 (82.4%)

34 (89.5%)

50 (86.2%)

0.576

 < 1 cm

10 (11.8%)

3 (7.9%)

3 (5.2%)

 

 < 2 cm

1 (1.2%)

1 (2.6%)

1 (1.7%)

 

 ≥2 cm

4 (4.7%)

0 (0.0%)

4 (6.9%)

 
  1. Unless indicated otherwise, data are presented as n (%)
  2. PDS, primary debulking surgery; DLS, diagnostic laparoscopic surgery; NACT, neoadjuvant chemotherapy; OP, operative; ΔHb, change in hemoglobin; IQR, interquartile range; ICU, intensive care unit